Allosteric modulators for
human health
About us
Overview
Addex Corporate Presentation
Our people
Executive Officers
Non-Executive Directors
Scientific Advisory Board
Contact
Privacy Policy
Pipeline
Research And Development
Clinical and Pre-Clinical Pipeline
Publications
Technology platform
Allosteric modulation
Our capabilities
Screening Assays
Chemistry
Partners & collaboration
Investors
Stock Data
Downloads
Register for email news
Corporate Governance
SEC Filings
News Events & Careers
Press releases
Events
Careers
Downloads
Guide to US ADSs for Six Shareholders
Download
Addex Corporate Presentation
Download
Financial Reports
2020 Annual Report &
Quarter 3 Report
&
Half Year Report
&
Quarter 1 Report
2019
Annual Report
&
Half Year Report
2018
Annual Report
&
Half Year Report
2017
Annual Report
&
Half Year Report
2016
Annual Report
&
Half Year Report
2015
Annual Report
&
Half Year Report
2014
Annual Report
&
Half Year Report
2013
Annual Report
&
Half Year Report
2012
Annual Report
&
Half Year Report
2011
Annual Report
&
Half Year Report
2010
Annual Report
&
Half Year Report
2009
Annual Report
&
Half Year Report
2008
Annual Report
&
Half Year Report
2007
Annual Report
&
Half Year Report
Analyst Reports
Van Leewenhoeck Jul-2020
Van Leewenhoeck Dec-2019
Van Leewenhoeck Aug-2019
Van Leewenhoeck Nov-2018
Van Leewenhoeck Jul-2018
Van Leewenhoeck Feb-2018
ValuationLAB Jan-2018
Van Leewenhoeck Oct-2017
General Meetings
2020 AGM
invitation
&
results
2019 AGM
invitation
&
results
2018 AGM
invitation
&
results
2018 EGM
invitation
&
results
2017 AGM
invitation
&
results
2016 AGM
invitation
&
results
2015 AGM
invitation
&
results
2014 AGM
invitation
&
results
2013 AGM
invitation
&
results
2012 AGM
invitation
&
results
2011 AGM
invitation
&
results
2010 AGM
invitation
&
results
2009 AGM
invitation
&
results
2008 AGM
invitation
& results
Prospectus
Private placement
(March 2018)
Private Placement
(August 2013)
IPO
(May 2007)
Back